Management of drug-related problems including drug-drug interactions caused by nirmatrelvir/ritonavir in paediatric patients with SARS-CoV-2

被引：2
|
作者：
Yalcin, Nadir [1 ,2 ]
Demirkan, Kutay [1 ]
机构：
[1] Hacettepe Univ, Dept Clin Pharm, Fac Pharm, TR-06100 Ankara, Turkey
[2] Erasmus MC, Dept Clin Pharm, Rotterdam, Netherlands
来源：
ARCHIVES OF DISEASE IN CHILDHOOD | 2023年 / 108卷 / 10期
关键词：
pharmacology; infectious disease medicine; global health;
D O I：
10.1136/archdischild-2022-324168
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Pharmacological Management of Cancer Patients: Focus on Drug-Drug Interactions
    Rashid, Anis
    Shah, Asim
    Scheurmeyer, Isabel
    Walker, Paul
    PSYCHO-ONCOLOGY, 2014, 23 : 43 - 43
  • [42] Drug-Drug Interactions in the Management of Patients With Pulmonary Arterial Hypertension
    Wu, Sheryl
    Hoang, Heather B.
    Yang, Jenny Z.
    Papamatheakis, Demosthenes G.
    Poch, David S.
    Alotaibi, Mona
    Lombardi, Sandra
    Rodriguez, Cynthia
    Kim, Nick H.
    Fernandes, Timothy M.
    CHEST, 2022, 162 (06) : 1360 - 1372
  • [43] POTENTIAL DRUG-DRUG INTERACTIONS IDENTIFIED AS DRUG-RELATED PROBLEMS IN THE TREATMENT OF HOSPITALIZED PATIENTS WITH GASTRITIS AND/OR DUODENITIS OR PEPTIC ULCER DISEASE IN LUBLIN (POLAND) - AN OBSERVATIONAL STUDY
    Serefko, Anna
    Korona-Glowniak, Izabela
    Szopa, Aleksandra
    Drozd, Mariola
    Prystupa, Andrzej
    Szymanska, Jolanta
    Malm, Anna
    Poleszak, Ewa
    ACTA POLONIAE PHARMACEUTICA, 2020, 77 (06): : 909 - 919
  • [44] DUTCH POLICY ON THE MANAGEMENT OF DRUG-RELATED PROBLEMS
    ENGELSMAN, EL
    BRITISH JOURNAL OF ADDICTION, 1989, 84 (02): : 211 - 218
  • [45] Severity and Management of Drug-Drug Interactions in Acute Geriatric Patients
    Lea, Marianne
    Rognan, Stine Eidhammer
    Koristovic, Radojka
    Wyller, Torgeir Bruun
    Molden, Espen
    DRUGS & AGING, 2013, 30 (09) : 721 - 727
  • [46] Overview of Drug-Drug Interactions Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) and Targeted Therapy and Supportive Care for Lung Cancer
    Anwar, Kaleem
    Nguyen, Lee
    Nagasaka, Misako
    Ou, Sai-Hong Ignatius
    Chan, Alexandre
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (02):
  • [47] Phenytoin enzyme induction for management of supratherapeutic tacrolimus levels due to drug-drug interaction with nirmatrelvir/ritonavir: Case series and discussion
    Marsh, Jennifer
    Logan, Angela T.
    Bilgili, Erin P.
    Bowman, Lyndsey J.
    Webb, Allyssa R.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024, 81 (13) : e345 - e352
  • [48] Naturally Occurring Mutations of SARS-CoV-2 Main Protease Confer Drug Resistance to Nirmatrelvir
    Hu, Yanmei
    Lewandowski, Eric M.
    Tan, Haozhou
    Zhang, Xiaoming
    Morgan, Ryan T.
    Zhang, Xiujun
    Jacobs, Lian M. C.
    Butler, Shane G.
    Gongora, Maura V.
    Choy, John
    Deng, Xufang
    Chen, Yu
    Wang, Jun
    ACS CENTRAL SCIENCE, 2023, 9 (08) : 1658 - 1669
  • [49] CORDITE: The Curated CORona Drug InTERactions Database for SARS-CoV-2
    Martin, Roman
    Loechel, Hannah F.
    Welzel, Marius
    Hattab, Georges
    Hauschild, Anne-Christin
    Heider, Dominik
    ISCIENCE, 2020, 23 (07)
  • [50] Drug-related problems in patients with rheumatoid arthritis
    Ma, Shu Ning
    Huri, Hasniza Zaman
    Yahya, Fariz
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2019, 15 : 505 - 524
12345